Rainer F Storb
Hematologist-Oncologist | Hematology & Oncology
University Of Washington Medical Ctr 1959 Ne Pacific St Seattle WA, 98195About
Dr. Rainer Storb is a hematologist oncologist practicing in Seattle, WA. Dr. Storb specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Genetic tracing of arterial graft flow surface endothelialization in allogeneic marrow transplanted dogs.
- Cyclosporine (CSP)or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial.
- Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
- Non-myeloablative transplants for malignant disease.
- Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce
- Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission.
- Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant.
- Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.
- BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
- Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation.
- Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
- Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences.
- The role of B cells in the pathogenesis of graft-versus-host disease.
- Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.
Rainer F Storb's Practice location
Rainer F Storb's reviews
Write ReviewRecommended Articles
- What Specialists Treat Multiple Myeloma?
If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...
- Superheroes Unite For Elementary Student Fighting Lymphoma
Anyone diagnosed with cancer knows how terrifying and debilitating the news can be. Now just imagine how horrible an experience it would be for an elementary school student to hear that they have cancer.It is a sad fact that thousands of children are diagnosed with cancer every year, and it is...
- Exercise Proven to Help Lymphoma Patients
People always say that exercise is the best medicine. It's been proven through many years of research that regular exercise is really important to maintain a healthy body and mind. Doctors are always reminding their patients of the benefits of physical exercise and the power it holds to fight...
- AstraZeneca Gains United States Approval for Lymphoma Drug
Some forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...
- Morphos Declared a "Breakthrough Therapy" for Lymphoma
MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
- Make-A-Wish Makes a Movie Star
Through their fundraising, on average in the United States and its territories, Make-A-Wish is able to grant the wish of a child every 34 minutes.How was it started?The Make-A-Wish Foundation started with the wish of one 7-year-old boy’s wish in 1980. Chris Grecius, who had leukemia, wanted to be...
Nearby Providers
- Dr. Nicole Kuderer M.D.825 Eastlake Ave E Seattle WA 98109
- Dr. Sheldon Z Goldberg MD515 Minor Ave Seattle WA 98104
- Dr. Sharmila Ahmed MD1101 MADISON ST SEATTLE WA 98104
- Dr. Elena G Chiorean M.D.825 EASTLAKE AVE E SEATTLE WA 98109
- Dr. Vincent J Picozzi MD1100 9th Ave Seattle WA 98101
- Dr. Naixi Nick Chen M.D., PH.D.900 Sw 16th St Renton WA 98057